To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?

Higgins, R

To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy? [electronic resource] - The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation Apr 2005 - 392-400 p. digital

Publication Type: Comparative Study; Journal Article; Multicenter Study

1053-2498

10.1016/j.healun.2004.01.002 doi


Adult
Aged
Antilymphocyte Serum--therapeutic use
Decision Making
Follow-Up Studies
Graft Rejection--drug therapy
HLA Antigens--immunology
Heart Transplantation
Humans
Immunosuppression Therapy--methods
Immunosuppressive Agents--therapeutic use
Middle Aged
Multivariate Analysis
Muromonab-CD3--therapeutic use
North America--epidemiology
Perioperative Care--methods
Retrospective Studies
Risk Factors
Severity of Illness Index
Survival Rate--trends
T-Lymphocytes--immunology